To the Editor,
Salvatore et al. [1] reported that SYNTAX score II (SS-II) might represent a useful tool to predict clinical events not only in ideal stable patients, but also in an unrestricted, real world population of patients with acute coronary syndrome and severe coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI).
SS-II briefly contains six clinical variables (age, sex, creatinine clearance, peripheral vascular disease, chronic obstructive pulmonary disease, and left ventricular ejection fraction) and two anatomical variables (anatomical SS and unprotected left main CAD) [2]. Residual SS (rSS) was designed and validated to quantify the burden of residual CAD after PCI. SS-II indicated a superior predictability for long-term mortality compared with SS [3]. SS-II may be a more useful tool than SS for predicting no-reflow phenomenon after primary PCI [4]. Additionally, prognostic significance of SS-II is widening, and it is applicable for clinical utility in valvular heart disease [5].
Residual SS-II, including rSS, postprocedural left ventricular ejection fraction, and postprocedural creatinine clearance might be a usefull tool to predict major adverse cardiac events and all-cause mortality. In this context, correlation of this study’s result with residual SS-II might be beneficial.
Disclosure: Author has nothing to disclose with regard to commercial support.
Footnotes
Peer review under responsibility of King Saud University.
References
- 1.Salvatore A., Boukhris M., Giubilato S., Tomasello S.D., Castaing M., Giunta R. Usefulness of SYNTAX score II in complex percutaneous coronary interventions in the setting of acute coronary syndrome. J Saudi Heart Assoc. 2016;28:63–72. doi: 10.1016/j.jsha.2015.07.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Farooq V., van Klaveren D., Steyerberg E.W., Meliga E., Vergouwe Y., Chieffo A. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet. 2013;381:639–650. doi: 10.1016/S0140-6736(13)60108-7. [DOI] [PubMed] [Google Scholar]
- 3.He J., Zhao H., Yu X., Li Q., Lv S., Chen F. SYNTAX score-II predicts long-term mortality in patients who underwent left main percutaneous coronary ıntervention treated with second-generation drug-eluting stents. Int Heart J. 2017;58:344–350. doi: 10.1536/ihj.16-292. [DOI] [PubMed] [Google Scholar]
- 4.Yesin M., Çağdaş M., Kalçık M., Uluganyan M., Efe S.Ç., Rencüzoğulları İ. Comparison of syntax score and syntax score II to predict “no reflow phenomenon” in patients with ST-segment elevation myocardial infarction. Int J Cardiovasc Imaging. 2017 doi: 10.1007/s10554-017-1200-5. [Epub ahead of print] [DOI] [PubMed] [Google Scholar]
- 5.Obeid S., Attinger-Toller A., Taramasso M., Pedrazzini G., Suetsch G., Landolt F. SYNTAX score II in patients with coronary artery disease undergoing percutaneous mitral repair with the MitraClip. Int J Cardiol. 2017;236:375–380. doi: 10.1016/j.ijcard.2017.02.049. [DOI] [PubMed] [Google Scholar]